You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH):雲生公司申請破產重整
格隆匯 08-05 18:51

格隆匯8月5日丨海正藥業(600267.SH)公佈,2016年以來,公司控股子公司雲南生物製藥有限公司(以下簡稱“雲生公司”)經營業績持續下滑、長期虧損,截至2020年6月30日,雲生公司未經審計淨資產為-3911萬元,已資不抵債。為進一步控制投資風險,雲生公司向人民法院提交破產重整申請,同時授權公司管理層在有關法律法規允許的範圍內具體組織實施對雲生公司的破產重整相關事宜。雲生公司破產重整,不會影響公司現有主營業務的生產經營,不對公司的持續經營造成影響。

因雲生公司破產重整尚待向具有管轄權的人民法院遞交申請,申請能否獲得受理,以及破產重整方案尚待確定,難以預估破產資產處置結果,對本公司合併報表的影響金額取決於法院是否裁定批准破產重整方案,如破產重整失敗將進入到破產清算程序,公司將根據最終破產重整結果,依據會計準則的規定進行相應的會計處理。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account